Insmed Inc. buy Royal Bank of Canada
Start price
08.08.25
/
50%
€94.50
Target price
08.08.26
€102.90
Performance (%)
-13.45%
Price
05.06.26
€89.19
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -13.45%. This prediction currently runs until 08.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.439% | -2.439% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Royal Bank Of Canada from $108.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat